Research Underlying Galectin's Development of GR-MD-02 in Cancer Presented at the Society for Immunotherapy of Cancer Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. HOOD
7. QCOM
8. ACN
9. AZN
10. ROIV

Go back to Research Underlying Galectin's Development of GR-MD-02 in Cancer Presented at the Society for Immunotherapy of Cancer Annual Meeting
GALECTIN (NASDAQ: GALT) Delayed: 4.14 -0.47 (10.2%)
Previous Close $4.61    52 Week High $3.05 
Open $4.60    52 Week Low $0.49 
Day High $4.65    P/E N/A 
Day Low $4.10    EPS $-1.32 
Volume 393,346